Correlation Between Mosaic Immunoengineerin and Sino Biopharmaceutica

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mosaic Immunoengineerin and Sino Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mosaic Immunoengineerin and Sino Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mosaic Immunoengineering and Sino Biopharmaceutical Ltd, you can compare the effects of market volatilities on Mosaic Immunoengineerin and Sino Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mosaic Immunoengineerin with a short position of Sino Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mosaic Immunoengineerin and Sino Biopharmaceutica.

Diversification Opportunities for Mosaic Immunoengineerin and Sino Biopharmaceutica

-0.28
  Correlation Coefficient

Very good diversification

The 3 months correlation between Mosaic and Sino is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Mosaic Immunoengineering and Sino Biopharmaceutical Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sino Biopharmaceutical and Mosaic Immunoengineerin is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mosaic Immunoengineering are associated (or correlated) with Sino Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sino Biopharmaceutical has no effect on the direction of Mosaic Immunoengineerin i.e., Mosaic Immunoengineerin and Sino Biopharmaceutica go up and down completely randomly.

Pair Corralation between Mosaic Immunoengineerin and Sino Biopharmaceutica

Given the investment horizon of 90 days Mosaic Immunoengineering is expected to generate 3.82 times more return on investment than Sino Biopharmaceutica. However, Mosaic Immunoengineerin is 3.82 times more volatile than Sino Biopharmaceutical Ltd. It trades about 0.06 of its potential returns per unit of risk. Sino Biopharmaceutical Ltd is currently generating about 0.02 per unit of risk. If you would invest  100.00  in Mosaic Immunoengineering on September 12, 2024 and sell it today you would lose (10.00) from holding Mosaic Immunoengineering or give up 10.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy57.95%
ValuesDaily Returns

Mosaic Immunoengineering  vs.  Sino Biopharmaceutical Ltd

 Performance 
       Timeline  
Mosaic Immunoengineering 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Mosaic Immunoengineering are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, Mosaic Immunoengineerin showed solid returns over the last few months and may actually be approaching a breakup point.
Sino Biopharmaceutical 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Sino Biopharmaceutical Ltd are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain primary indicators, Sino Biopharmaceutica showed solid returns over the last few months and may actually be approaching a breakup point.

Mosaic Immunoengineerin and Sino Biopharmaceutica Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mosaic Immunoengineerin and Sino Biopharmaceutica

The main advantage of trading using opposite Mosaic Immunoengineerin and Sino Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mosaic Immunoengineerin position performs unexpectedly, Sino Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sino Biopharmaceutica will offset losses from the drop in Sino Biopharmaceutica's long position.
The idea behind Mosaic Immunoengineering and Sino Biopharmaceutical Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets